Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Therapeutic Strategies for Neurological Disorders: From Natural Compounds to Innovative Molecular Designs

Author(s): Antoni Camins and Miren Ettcheto

Volume 28, Issue 14, 2022

Published on: 13 July, 2022

Page: [i - ii] Pages: 2

DOI: 10.2174/138161282814220713113802

« Previous
[1]
Avan A, Hachinski V. Stroke and dementia, leading causes of neurological disability and death, potential for prevention. Alzheimers Dement 2021; 17(6): 1072-6.
[2]
Feigin VL, Vos T, Nichols E, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 2020; 19(3): 255-65.
[3]
2021.
[4]
Qiu C, Kivipelto M, Strausset E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009; 11(2): 111-28.
[5]
Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2(10)a006296
[6]
Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology 2020; 54(Suppl. 2): 185-91.
[7]
Dalic L, et al. Managing drug-resistant epilepsy: challenges and solutions. Neuropsychiatr Dis Treat 2016; 12: 2605-16.
[8]
Giorgi FS, Saccaro LF, Busceti CL, Biagioni F, Fornai F. Epilepsy and Alzheimer’s Disease: Potential mechanisms for an association. Brain Res Bull 2020; 160: 107-20.
[9]
Fagiolino P, Vázquez M. Tissue Drug Concentration. Curr Pharm Des 2022; 28(14): 1109-23.
[10]
Pomilio AB, Vitale AA, Lazarowski AJ. Neuroproteomics Chip-Based Mass Spectrometry and Other Techniques for Alzheimer´S Disease Biomarkers - Update. Curr Pharm Des 2022; 28(14): 1124-51.
[11]
Pomilio AB, Vitale AA, Lazarowski AJ. Uncommon Noninvasive Biomarkers for the Evaluation and Monitoring of the Etiopathogenesis of Alzheimer’s Disease. Curr Pharm Des 2022; 28(14): 1152-69.
[12]
Manzine PR, Vatanabe IP, Grigoli MM, et al. Potential Protein Blood-Based Biomarkers in Different Types of Dementia: A Therapeutic Overview. Curr Pharm Des 2022; 28(14): 1170-86.
[13]
Marín-Prida J, Liberato JL, Llópiz-Arzuaga A, et al. Novel Insights into the Molecular Mechanisms Involved in the Neuroprotective Effects of C-Phycocyanin Against Brain Ischemia in Rats. Curr Pharm Des 2022; 28(14): 1187-97.
[14]
Chacón LMM, García LG, García-Ramón KB, et al. Common ictal and interictal perfusion patterns. A window into the epileptogenic network and SUDEP mechanism in Drug Resistant Focal Epilepsy? Curr Pharm Des 2022; 28(14): 1198-209.

Rights & Permissions Print Cite
Article Metrics
13
1
© 2024 Bentham Science Publishers | Privacy Policy